Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill aims to prohibit tianeptine and similar dangerous products from being sold in the United States.
The problem
Tianeptine is a drug sold as dietary supplements or nootropics that can be addictive and harmful. It may be marketed under names like Za Za Red or Tianna, affecting public health.
The proposal
The bill would ban tianeptine and related substances from being sold, distributed, or marketed in America. It establishes regulatory controls treating these products as controlled substances or prohibited items.
The impact
Consumers who use these products would no longer access them legally. Retailers and manufacturers would stop selling them. Healthcare providers may see reduced related health issues.
Removes potentially addictive and harmful substances from the marketplace. Prevents people from unknowingly consuming dangerous products marketed as safe supplements.
Addresses products sold as supplements to avoid FDA oversight. Establishes clear legal status for tianeptine and similar compounds.
May decrease emergency room visits and hospitalizations related to tianeptine use and withdrawal. Reduces strain on healthcare systems from treating related conditions.
Prevents widespread addiction and dependency problems before they escalate. Protects vulnerable populations from accessing habit-forming substances.
Removes legal access to products some adults use without serious harm. Restricts personal freedom for individuals who use these substances responsibly.
Retailers and manufacturers selling these products face inventory losses and business disruption. Small businesses in the supplement industry may suffer revenue decline.
Banning products can drive users toward illegal or underground markets. Reduces government ability to monitor product safety and purity.
Requires FDA and law enforcement resources to monitor and prevent sales. Products may be relabeled or repackaged to evade restrictions.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.